Bilateral superficial cervical plexus block for post-operative analgesia in thyroid surgeries using ropivacaine(0.2%) with or without dexmedetomidine
Phase 4
- Conditions
- Health Condition 1: E079- Disorder of thyroid, unspecifiedHealth Condition 2: E079- Disorder of thyroid, unspecified
- Registration Number
- CTRI/2018/10/016018
- Lead Sponsor
- MB hospital Udaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
the study conducted on 60 patients of ASA Grade I & II of either sex, aged 18 to 60 years, having a euthyroid state, who undergone elective thyroid surgeries under general anesthesia and after completion of surgery bilateral superficial cervical plexus block given.
Exclusion Criteria
patient refusal,age <18yrs, ASA grade >2,patient havong severe respiratory,cardiac or renal disorders,and acute psychiatric illness,infection at the injection site,allergy to agent used,morbid obesity (bmi >35),coagulation disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative analgesia. <br/ ><br>To determine the adverse effects, if any of ropivacaine and dexmedetomidine. <br/ ><br>To study the post-operative pain management, rescue analgesic requirement, sedation in patients, hospital stay and patient comfort. <br/ ><br>Timepoint: to study post-operative analgesia at 0hour,4hour,8hour,12hour and 24hour <br/ ><br>
- Secondary Outcome Measures
Name Time Method To study the post-operative pain management, rescue analgesic requirement, sedation in patients, hospital stay and patient comfort.Timepoint: to study post-operative analgesia at 0hour,4hour,8hour,12hour and 24hour